fr
Article scientifique
Anglais

5-HT2A receptor SPECT imaging with [¹²³I]R91150 under P-gp inhibition with tariquidar: More is better?

Publié dansNuclear medicine and biology, vol. 43, no. 1, p. 81-88
Date de publication2016
Résumé

Pharmacological P-glycoprotein (P-gp) inhibition with tariquidar (TQD) is considered a promising strategy for the augmentation of radiotracer brain uptake. However, a region-dependent effect may compromise the robustness of quantitative studies. For this reason, we studied the effect of a TQD pretreatment on 5-HT2A imaging with [(123)I]R91150 and compared results with those obtained in Mdr1a knock-out (KO) rats.

Mots-clés
  • Animals
  • Gene Knockout Techniques
  • Iodine Radioisotopes
  • Male
  • P-Glycoprotein/antagonists & inhibitors/deficiency/genetics
  • Piperidines
  • Quinolines/pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Serotonin, 5-HT2A/metabolism
  • Tomography, Emission-Computed, Single-Photon/methods
Citation (format ISO)
TSARTSALIS, Stergios et al. 5-HT2A receptor SPECT imaging with [¹²³I]R91150 under P-gp inhibition with tariquidar: More is better? In: Nuclear medicine and biology, 2016, vol. 43, n° 1, p. 81–88. doi: 10.1016/j.nucmedbio.2015.09.003
Fichiers principaux (1)
Article (Published version)
accessLevelRestricted
Identifiants
ISSN du journal0969-8051
522vues
2téléchargements

Informations techniques

Création10/03/2017 17:27:00
Première validation10/03/2017 17:27:00
Heure de mise à jour15/03/2023 01:27:05
Changement de statut15/03/2023 01:27:04
Dernière indexation16/01/2024 23:28:11
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack